Huntington-kór: vizsgálatok itt: Németország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- Berlin, Bochum, Bonn, Lübeck, Muenster, Taufkirchen (Vils), Ulm
- Életkor
- 25 év and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - 3. fázisTaking peoplePridopidine Phase 3 Study in Huntington's Disease
- Where
- Aachen, Bochum, Erlangen, Muenster, Taufkirchen (Vils), Ulm
- Életkor
- 23 év to 65 év
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - 2. fázisNot yet taking people in NémetországA Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3
- Where
- Tuebingen
- Életkor
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- Vico Therapeutics B.V.
See details and how to join2026-526408-60-00 · EU 2026-526408-60-00 - 1. fázisTaking peopleA Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
- Where
- Berlin, Bochum, Bonn, Dresden, Münster, Taufkirchen, Ulm
- Életkor
- 25 év to 70 év
- People
- 66 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06585449 - 3. fázisTaking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Aachen, Berlin, Bochum, Bonn, Dresden, Duesseldorf, Erlangen, Freiburg im Breisgau, Luebeck, Muenster, Taufkirchen (Vils), Tuebingen, Ulm, Wuerzburg
- Életkor
- 21 év to 70 év
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - 1/2. fázisTaking peopleA Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
- Where
- Berlin, Bochum, Bonn, Tuebingen
- Életkor
- 25 év to 60 év
- People
- 68 worldwide
- Run by
- Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00 - 4. fázisTaking peoplePatient- and care-related benefits of amyloid PET imaging (ENABLE)
- Where
- Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Leipzig, Magdeburg, Mainz, Mannheim, Marburg, Munich, Rostock, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 1126
- Run by
- Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
See details and how to join2023-503705-10-00 · EU 2023-503705-10-00 - No phaseTaking peopleHDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- Where
- Bochum, Dresden, Erlangen, Münster, Taufkirchen, Ulm
- Életkor
- 11 év to 75 év
- People
- 2500 worldwide
- Run by
- University College, London
See details and how to joinNCT02855476 - No phaseTaking peopleEnroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Where
- Aachen, Berlin, Bochum, Dresden, Erlangen, Freiburg im Breisgau, Kassel, Lübeck, Marburg, Munich, Münster, Taufkirchen, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- CHDI Foundation, Inc.
See details and how to joinNCT01574053